Improving outcomes of first‐episode psychosis: an overview

P Fusar‐Poli, PD McGorry, JM Kane - World psychiatry, 2017 - Wiley Online Library
Outcomes of psychotic disorders are associated with high personal, familiar, societal and
clinical burden. There is thus an urgent clinical and societal need for improving those …

Predictors of functional recovery in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies

O Santesteban-Echarri, M Paino, S Rice… - Clinical psychology …, 2017 - Elsevier
Background Three out of four first-episode psychosis (FEP) patients achieve clinical
remission following treatment. Unfortunately, functional recovery lags behind symptomatic …

A method for tapering antipsychotic treatment that may minimize the risk of relapse

MA Horowitz, S Jauhar, S Natesan… - Schizophrenia …, 2021 - academic.oup.com
The process of stop** antipsychotics may be causally related to relapse, potentially linked
to neuroadaptations that persist after cessation, including dopaminergic hypersensitivity …

[LIBRO][B] Recovery, meaning-making, and severe mental illness: A comprehensive guide to metacognitive reflection and insight therapy

PH Lysaker, RE Klion - 2017 - taylorfrancis.com
Recovery, Meaning-Making, and Severe Mental Illness offers practitioners an integrative
treatment model that will stimulate and harness their creativity, allowing for the formation of …

Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology

TRE Barnes, R Drake, C Paton… - Journal of …, 2020 - journals.sagepub.com
These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

The diagnosis and clinical management of the neuropsychiatric manifestations of lupus

M Govoni, A Bortoluzzi, M Padovan, E Silvagni… - Journal of …, 2016 - Elsevier
Neuropsychiatric (NP) involvement in Systemic Lupus Erythematosus (SLE), can be a
severe and troubling manifestation of the disease that heavily impacts patient's health …

Transforming the treatment of schizophrenia in the United States: the RAISE initiative

LB Dixon, HH Goldman, VH Srihari… - Annual Review of …, 2018 - annualreviews.org
The schizophrenia spectrum disorders are neurodevelopmental illnesses with a lifetime
prevalence near 1%, producing extensive functional impairment and low expectations for …

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic …

MJH Begemann, IA Thompson, W Veling, SS Gangadin… - Trials, 2020 - Springer
Background Antipsychotic medication is effective for symptomatic treatment in schizophrenia-
spectrum disorders. After symptom remission, continuation of antipsychotic treatment is …

Heterogeneity in treatment outcomes and incomplete recovery in first episode psychosis: does one size fit all?

SL Griffiths, PA Lalousis, SJ Wood… - Translational …, 2022 - nature.com
The heterogeneity in recovery outcomes for individuals with First Episode Psychosis (FEP)
calls for a strong evidence base to inform practice at an individual level. Between 19–89% of …

Diagnosis, prognosis, and treatment of brief psychotic episodes: a review and research agenda

P Fusar-Poli, GS De Pablo, RP Rajkumar… - The Lancet …, 2022 - thelancet.com
Brief psychotic episodes represent an intriguing paradox in clinical psychiatry because they
elude the standard knowledge that applies to the persisting psychotic disorders such as …